Literature DB >> 15067040

Cutting edge: early IL-4 production governs the requirement for IL-27-WSX-1 signaling in the development of protective Th1 cytokine responses following Leishmania major infection.

David Artis1, Leanne M Johnson, Karen Joyce, Christiaan Saris, Alejandro Villarino, Christopher A Hunter, Phillip Scott.   

Abstract

There are conflicting reports on the requirements for the IL-27-WSX-1 pathway in the development of Th type 1 responses and resistance to intracellular pathogens; although early IFN-gamma production and resistance to Leishmania major are impaired in the absence of WSX-1 signaling, WSX-1(-/-) mice generate robust IFN-gamma responses and control infection with other intracellular protozoan pathogens. In this report, we resolve these conflicting observations and demonstrate that, in the absence of IL-4, WSX-1 is not required for early IFN-gamma production and control of L. major. Thus, the requirement for WSX-1 signaling in Th type 1 cell differentiation is restricted to conditions in which IL-4 is produced.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15067040     DOI: 10.4049/jimmunol.172.8.4672

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  41 in total

1.  Parasites: what are they good for?

Authors:  Jason S Stumhofer; P'ng Loke
Journal:  Curr Immunol Rev       Date:  2013-08-01

2.  Activation of IL-27 p28 gene transcription by interferon regulatory factor 8 in cooperation with interferon regulatory factor 1.

Authors:  Jidong Zhang; Xuesong Qian; Huan Ning; Jianjun Yang; Huabao Xiong; Jianguo Liu
Journal:  J Biol Chem       Date:  2010-04-30       Impact factor: 5.157

3.  Transcriptional suppression of IL-27 production by Mycobacterium tuberculosis-activated p38 MAPK via inhibition of AP-1 binding.

Authors:  Jidong Zhang; Xuesong Qian; Huan Ning; Christopher S Eickhoff; Daniel F Hoft; Jianguo Liu
Journal:  J Immunol       Date:  2011-04-11       Impact factor: 5.422

Review 4.  Molecular pathways in the induction of interleukin-27-driven regulatory type 1 cells.

Authors:  Caroline Pot; Lionel Apetoh; Amit Awasthi; Vijay K Kuchroo
Journal:  J Interferon Cytokine Res       Date:  2010-06       Impact factor: 2.607

Review 5.  The emerging role of Interleukin 27 in inflammatory arthritis and bone destruction.

Authors:  Iannis E Adamopoulos; Stefan Pflanz
Journal:  Cytokine Growth Factor Rev       Date:  2012-11-16       Impact factor: 7.638

6.  Temporal regulation of interleukin-12p70 (IL-12p70) and IL-12-related cytokines in splenic dendritic cell subsets during Leishmania donovani infection.

Authors:  Asher Maroof; Paul M Kaye
Journal:  Infect Immun       Date:  2007-11-12       Impact factor: 3.441

Review 7.  Pro- and anti-inflammatory cytokines in cutaneous leishmaniasis: a review.

Authors:  Nahid Maspi; Amir Abdoli; Fathemeh Ghaffarifar
Journal:  Pathog Glob Health       Date:  2016-09-23       Impact factor: 2.894

Review 8.  Interleukin-27: balancing protective and pathological immunity.

Authors:  Christopher A Hunter; Rob Kastelein
Journal:  Immunity       Date:  2012-12-14       Impact factor: 31.745

9.  Immunological perspectives of leishmaniasis.

Authors:  Susanne Nylén; Shalini Gautam
Journal:  J Glob Infect Dis       Date:  2010-05

Review 10.  A pivotal role for interleukin-27 in CD8+ T cell functions and generation of cytotoxic T lymphocytes.

Authors:  Noriko Morishima; Izuru Mizoguchi; Masae Okumura; Yukino Chiba; Mingli Xu; Motomu Shimizu; Masanori Matsui; Junichiro Mizuguchi; Takayuki Yoshimoto
Journal:  J Biomed Biotechnol       Date:  2010-04-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.